Infectious Bursal Disease Virus (IBDV), commonly known as Gumboro disease, is one of the most serious viral diseases affecting poultry, particularly broiler chickens. It exerts a direct impact on the immune system, thereby compromising vaccination efficacy and overall production performance. Scientifically identified as IBDV, it causes significant economic losses in the global poultry industry.

The virus belongs to the genus Avibirnavirus within the family Birnaviridae. It is a non-enveloped virus containing a double-stranded RNA (dsRNA) genome consisting of two segments, A and B. The primary target organ is the Bursa of Fabricius, a specialized immune organ responsible for the maturation of B-lymphocytes in young birds.

Strains and Pathotypes

IBDV strains are classified into several types based on virulence and genetic structure:

Classical Strains: First emerged in the United States in 1957. They cause overt clinical signs with moderate mortality and generally respond well to traditional vaccination programs.

Variant Strains: Emerged in the 1980s in the US. These cause immunosuppression that may occur without clear clinical symptoms, leading to vaccination failure despite the absence of high mortality rates.

Very Virulent Strains (vvIBDV): Emerged in the late 1980s in Europe and the Middle East. They are characterized by high mortality rates (reaching 50–70%) accompanied by severe hemorrhages, inflammation, and rapid bursal atrophy.

Modern Variant Strains: Recently identified, first monitored in China since 2015. These typically cause subclinical infections with severe immunosuppression and have been recently recorded in Egypt.

Clinical Signs and Pathology

Clinical symptoms usually appear between 3 to 6 weeks of age, including lethargy, anorexia, white watery diarrhea, dehydration, and sudden death.

Upon post-mortem examination, the Bursa of Fabricius initially shows enlargement due to inflammation and congestion, followed by rapid atrophy within a few days. Hemorrhages may also be observed in the thigh and breast muscles, along with occasional renal enlargement or congestion.

Microscopically, severe lymphocyte depletion occurs, leading to marked immunosuppression, poor vaccine response, and increased susceptibility to secondary infections. In subclinical cases, overt symptoms may be absent, but permanent bursal atrophy leads to persistent immune deficiency.

New Variant Strains (A2dB1b)

Since 2015, five new variant strains have been reported in China, causing a widespread epidemic of Gumboro disease in a qualitatively new form. Compared to non-variant strains, amino acid substitutions were observed in the VP2 protein of the Chinese strains, showing distinct differences from American variants.

It is believed these strains resulted from the migration of North American variants to China during the 1990s, followed by cryptic circulation until the variant strains broke out in their new form, classified as A2dB1b.

Despite their recent discovery, these new IBDV variants have become dominant genotypes in several Asian countries, including China, South Korea, Malaysia, and Japan. Their spread to Egypt remained unclear until officially reported during 2022–2023, subsequently becoming part of the epidemiological landscape in Egypt.

Characteristics of the Variant Strain:

Does not typically cause severe symptoms like vvIBDV but leads to dangerous immunosuppression.

Observation: Mild lethargy, ruffled feathers, decreased feed intake, poor growth rates, flock lack of uniformity, and occasionally mild diarrhea.

Lesions: Rapid bursal atrophy with thinning of the bursal wall.

Impact: Weak response to vaccines (e.g., Newcastle Disease, Infectious Bronchitis), increased secondary infections (e.g., E. coli, CRD), and elevated mortality due to other diseases.

Diagnosis and Control

Diagnosis is achieved through:

Measuring the Bursa-to-Body Weight Ratio.

Histopathological examination of the Bursa of Fabricius.

RT-PCR testing to identify the specific variant strain.

Serological testing (ELISA).

Disease control relies on:

Monitoring maternally derived antibody (MDA) levels (for both classical and variant strains) during the early stages of the bird’s life.

Regular vaccination using appropriate vaccines.

Implementation of effective biosecurity programs.

Periodic genetic monitoring of circulating strains to select the optimal vaccination protocol.

Conclusion:

IBDV remains a major challenge for the poultry industry in Egypt due to its ability to mutate and cause immunosuppression, affecting productivity and vaccine efficiency. A thorough understanding of circulating strains and updated control strategies are the cornerstones of minimizing economic losses.